Jeanne Beker and Dr. Anthony Lang at P4P2019

Research Supported

Raising funds for Parkinson’s Research

The proceeds from our events fund groundbreaking research into the cause and cure for Parkinson’s Disease. Since 2019, they have been directed toward the Parkinson’s Research Excellence Fund at the Edmond J Safra Program in Parkinson’s Disease, at the Krembil Brain Institute, Toronto Western Hospital, UHN. They have also been directed toward three areas represented by the awards below.

The Edmond J. Safra Program in Parkinson's Disease: Supporting leading-edge treatment and research

2019-2022 | Dr. Anthony Lang

The Edmond J. Safra Program in Parkinson’s Disease is a program of the Krembil Brain Institute at Toronto Western Hospital.

The Program was established in 1994 and contains the long-standing Morton and Gloria Shulman Movement Disorders Clinic. The Program and Clinic specialize in leading-edge treatment and research for movement disorders. The Program is a Parkinson’s Foundation Center of Excellence, led by Dr. Anthony Lang, who is recognized as one of Canada’s leading experts in Parkinson’s disease.

Through the support of the Porridge for Parkinson’s 2019 event, the Movement Disorders Fellowship Program at Toronto Western Hospital has provided two Fellows with a unique opportunity to receive superb education, mentorship and clinical experiences through video meetings, research rounds and journal clubs. Dr. Daniel Garbin Di Luca and Dr. Diana Olszewska are able to continue their research to become experts in their field, and collaborate with movement disorders clinicians and research leaders to ultimately provide patients with the best clinical care possible. Read more

Read about our tour of the UHN PD research facilities

Graduate and Fellowship Awards: Helping researchers with projects that will benefit Parkinson’s research

Facilitated by Parkinson’s Canada

2017 | Anita Abeyesekera

Study of Hypophonia, the soft speech that is often a characteristic of Parkinson’s disease. Read more

2017 | Dr. Alexandre Boutet

Demystifying neuromodulation of dysfunctional brain circuits in Parkinson’s disease patients with deep brain stimulation. Read more

2017 | Cricia Rinchon

Abnormal neuroplasticity in movement disorders. Read more

2015 | Ms. Sarah Coakeley

Biomarkers – Diagnosing rare forms of Parkinson’s disease. University of Toronto (Centre for Addiction and Mental Health). Read more

2015 | Ms. Chelsia Kadgien

VPS35’s role in transporting proteins that help brain cells communicate. University of British Columbia. Read more

2015 | Dr. Natasha Radhu

Biomarkers – Bringing the brain back to a healthy balance. Toronto Western Research Institute (University Health Network). Read More

2013 | Mr. Jean-Francois Daneault

Subthalamic deep brain stimulation in Parkinson’s disease: Effect on the mobility of patients and their caregiver. McGill University. Read more

2013 | Dr. Karl Grenier

The interaction between PINK1 and the Mitochondrial Processing Peptidase: Defining the role of Mitochondrial import defects in Parkinson’s Disease. McGill University. Read more

Pilot Project Grants: Advancing promising new research by established researchers with a speciality in Parkinson's Disease.

Facilitated by Parkinson’s Canada

2017 | Simon Wing

Establishing a new link between brain and body. Read more

2015 | Dr. Jonathan Brotchie

Evaluation of chloroquine as a disease-modifying treatment for Parkinson’s disease. University of Toronto. Read more

2015 | Dr. Bradley MacIntosh

Cognitive Impairment – The pulsating brain and its implications for Parkinson’s disease. University of Toronto (Sunnybrook). Read more

2014 | Dr. Mark Carpenter

A novel fMRI approach to investigating the pathophysiology of postural instability in Parkinson’s Disease. University of British Columbia. Read more

2013 | Dr. Abbas Sadikot

Creation of a Novel Computerized MRI-Integrated 3-D Histochemical Atlas of Parkinson’s Disease Brain. Montreal Neurological Institute, McGill University.

2011 | Dr. Edward Fon

Regulation of Parkin function by deubiquitination. McGill University. Read more

2010 | Dr. Michael Schlossmacher

Characterization and validation of pharmacologically-driven signalling pathways to lower alpha-synuclein: Implications for Parkinson disease. Ottawa Health Research Institute.